Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar:29 Suppl 1:S1-S7.
doi: 10.1097/IJG.0000000000001451.

Evolving Guidelines for Intracameral Injection

Jeffrey M Liebmann  1 , Keith Barton  2 , Robert N Weinreb  3 , David A Eichenbaum  4 , Preeya K Gupta  5 , Cathleen M McCabe  6 , Jeremy D Wolfe  7 , Iqbal Ahmed  8   9 , Arsham Sheybani  10 , E Randy Craven  11
Affiliations
Review

Evolving Guidelines for Intracameral Injection

Jeffrey M Liebmann et al. J Glaucoma. 2020 Mar.

Abstract

Purpose: To review evidence and provide guidelines on intracameral (ICM) injection techniques and monitoring.

Materials and methods: A review of published literature on ICM injection and intravitreal injections formed the basis for roundtable deliberations by an expert panel of ophthalmologists.

Results: ICM injection as a way to deliver medications is growing in popularity. However, there is limited published literature and no standard approach to best practices for ICM injections, particularly when not accompanying another surgical procedure. Fortunately, there is long clinical experience with ICM manipulation and a large body of evidence surrounding intravitreal injections that has provided important guidance. The expert panel formulates several concrete guidelines and many suggested techniques to help physicians safely and effectively employ ICM injections.

Conclusions: This committee addressed the many considerations surrounding ICM injection of drugs or implants and agree that it is a safe and effective surgical procedure when performed with appropriate training and according to established safe practices.

PubMed Disclaimer

Comment in

References

    1. Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728–740.
    1. Gomes BF, Paredes AF, Madeira N, et al. Assessment of eye drop instillation technique in glaucoma patients. Arq Bras Oftalmol. 2017;80:238–241.
    1. Gao X, Yang Q, Huang W, et al. Evaluating eye drop instillation technique and its determinants in glaucoma patients. J Ophthalmol. 2018;2018:1376020.
    1. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(suppl 1):S57–S68.
    1. Aguayo Bonniard A, Yeung JY, Chan CC, et al. Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opin Drug Metab Toxicol. 2016;12:1279–1289.

Publication types

MeSH terms

Substances